126 related articles for article (PubMed ID: 11337133)
1. Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women.
van Amelsvoort TA; Abel KM; Robertson DM; Daly E; Critchley H; Whitehead M; Murphy DG
Psychoneuroendocrinology; 2001 Jul; 26(5):493-502. PubMed ID: 11337133
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen fails to affect central serotonergic tone but increases indices of anxiety in female rhesus macaques.
Mook D; Felger J; Graves F; Wallen K; Wilson ME
Psychoneuroendocrinology; 2005 Apr; 30(3):273-83. PubMed ID: 15511601
[TBL] [Abstract][Full Text] [Related]
3. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
[TBL] [Abstract][Full Text] [Related]
4. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
Prochazka H; Sjögren M; Agren H
J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
[TBL] [Abstract][Full Text] [Related]
5. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M
Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
[TBL] [Abstract][Full Text] [Related]
6. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
Williamson DJ; McTavish SF; Park SB; Cowen PJ
Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
[TBL] [Abstract][Full Text] [Related]
7. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
Monteleone P; Catapano F; Bortolotti F; Maj M
Biol Psychiatry; 1997 Aug; 42(3):175-80. PubMed ID: 9232209
[TBL] [Abstract][Full Text] [Related]
8. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
[TBL] [Abstract][Full Text] [Related]
9. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects.
Cleare AJ; Bond AJ
Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176
[TBL] [Abstract][Full Text] [Related]
10. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
[TBL] [Abstract][Full Text] [Related]
11. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
[TBL] [Abstract][Full Text] [Related]
12. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
[TBL] [Abstract][Full Text] [Related]
13. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
Flory JD; Manuck SB; Perel JM; Muldoon MF
Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
Young AH; Rue J; Odontiadis J; Cowen PJ
Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine.
Reist C; Mazzanti C; Vu R; Tran D; Goldman D
Am J Med Genet; 2001 May; 105(4):363-8. PubMed ID: 11378851
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women.
van Amelsvoort T; Murphy DG; Robertson D; Daly E; Whitehead M; Abel K
Psychoneuroendocrinology; 2003 Jan; 28(1):101-12. PubMed ID: 12445839
[TBL] [Abstract][Full Text] [Related]
17. D-fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients.
Jones H; Curtis VA; Wright P; Pilowsky LS; Lucey JV
Psychiatry Res; 2002 Dec; 113(1-2):41-7. PubMed ID: 12467944
[TBL] [Abstract][Full Text] [Related]
18. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375
[TBL] [Abstract][Full Text] [Related]
19. Retest reliability of prolactin response to dl-fenfluramine challenge in adults.
Flory JD; Manuck SB; Muldoon MF
Neuropsychopharmacology; 2002 Feb; 26(2):269-72. PubMed ID: 11790522
[TBL] [Abstract][Full Text] [Related]
20. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
Cleare AJ; Murray RM; O'Keane V
Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
